158 related articles for article (PubMed ID: 22288969)
1. Comparative evaluation of high-throughput small-core (0.6-mm) and large-core (2-mm) thyroid tissue microarray: is larger better?
Jones S; Prasad ML
Arch Pathol Lab Med; 2012 Feb; 136(2):199-203. PubMed ID: 22288969
[TBL] [Abstract][Full Text] [Related]
2. Validation of tissue microarray technology in malignant peripheral nerve sheath tumours.
Cunha KS; Caruso AC; Gonçalves AS; Bernardo VG; Pires AR; da Fonseca EC; de Faria PA; da Silva LE; Geller M; de Moura-Neto RS; Lopes VS
J Clin Pathol; 2009 Jul; 62(7):629-33. PubMed ID: 19318344
[TBL] [Abstract][Full Text] [Related]
3. Robust gridding of TMAs after whole-slide imaging using template matching.
Lahrmann B; Halama N; Westphal K; Ernst C; Elsawaf Z; Sinn P; Bosch FX; Dickhaus H; Jäger D; Schirmacher P; Grabe N
Cytometry A; 2010 Dec; 77(12):1169-76. PubMed ID: 20662092
[TBL] [Abstract][Full Text] [Related]
4. Tissue microarray-based immunohistochemical study can significantly underestimate the expression of HER2 and progesterone receptor in ductal carcinoma in situ of the breast.
Lin Y; Hatem J; Wang J; Quinn A; Hicks D; Tang P
Biotech Histochem; 2011 Oct; 86(5):345-50. PubMed ID: 20701550
[TBL] [Abstract][Full Text] [Related]
5. Comparison of tissue microarray and full section in immunohistochemistry of gastrointestinal stromal tumors.
Kwon MJ; Nam ES; Cho SJ; Park HR; Shin HS; Park JH; Park CH; Lee WJ
Pathol Int; 2009 Dec; 59(12):851-6. PubMed ID: 20021609
[TBL] [Abstract][Full Text] [Related]
6. Automated image analysis for high-throughput quantitative detection of ER and PR expression levels in large-scale clinical studies: the TEAM Trial Experience.
Faratian D; Kay C; Robson T; Campbell FM; Grant M; Rea D; Bartlett JM
Histopathology; 2009 Nov; 55(5):587-93. PubMed ID: 19912364
[TBL] [Abstract][Full Text] [Related]
7. Validation of usefulness of tissue microarray technology in primary tumours of the canine and feline central nervous system.
Wohlsein P; Recker T; Rohn K; Baumgärtner W
J Comp Pathol; 2012 May; 146(4):320-6. PubMed ID: 22000078
[TBL] [Abstract][Full Text] [Related]
8. Virtual tissue microarrays: a novel and viable approach to optimizing tissue microarrays for biomarker research applied to ductal carcinoma in situ.
Quintayo MA; Starczynski J; Yan FJ; Wedad H; Nofech-Mozes S; Rakovitch E; Bartlett JM
Histopathology; 2014 Jul; 65(1):2-8. PubMed ID: 24267587
[TBL] [Abstract][Full Text] [Related]
9. Validation of tissue microarray technology in endometrioid cancer of the endometrium.
Fons G; Hasibuan SM; van der Velden J; ten Kate FJ
J Clin Pathol; 2007 May; 60(5):500-3. PubMed ID: 16822874
[TBL] [Abstract][Full Text] [Related]
10. Tissue microarrays: construction and uses.
Fowler CB; Man YG; Zhang S; O'Leary TJ; Mason JT; Cunningham RE
Methods Mol Biol; 2011; 724():23-35. PubMed ID: 21370004
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic usefulness of HBME1, galectin-3, CK19, and CITED1 and evaluation of their expression in encapsulated lesions with questionable features of papillary thyroid carcinoma.
Scognamiglio T; Hyjek E; Kao J; Chen YT
Am J Clin Pathol; 2006 Nov; 126(5):700-8. PubMed ID: 17050067
[TBL] [Abstract][Full Text] [Related]
12. Tissue microarray is a reliable method for immunohistochemical analysis of pleomorphic adenoma.
Fonseca FP; de Andrade BA; Rangel AL; Della Coletta R; Lopes MA; de Almeida OP; Vargas PA
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jan; 117(1):81-8. PubMed ID: 24332331
[TBL] [Abstract][Full Text] [Related]
13. Tissue microarrays from renal cell tumors: exclusion criteria and rate of exclusion.
Hager M; Kolbitsch C; Tiefenthaler W; Haufe H; Kemmerling R; Lucia Moser P
Scand J Urol Nephrol; 2007; 41(6):485-9. PubMed ID: 17853046
[TBL] [Abstract][Full Text] [Related]
14. Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c.
Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Andersen J; Overgaard J
Acta Oncol; 2008; 47(4):591-9. PubMed ID: 18465327
[TBL] [Abstract][Full Text] [Related]
15. Tissue microarrays are reliable tools for the clinicopathological characterization of lung cancer tissue.
Schmidt LH; Biesterfeld S; Kümmel A; Faldum A; Sebastian M; Taube C; Buhll R; Wiewrodt R
Anticancer Res; 2009 Jan; 29(1):201-9. PubMed ID: 19331151
[TBL] [Abstract][Full Text] [Related]
16. A new approach to the validation of tissue microarrays.
Goethals L; Perneel C; Debucquoy A; De Schutter H; Borghys D; Ectors N; Geboes K; McBride WH; Haustermans KM
J Pathol; 2006 Apr; 208(5):607-14. PubMed ID: 16435284
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression.
Mucci NR; Akdas G; Manely S; Rubin MA
Hum Pathol; 2000 Apr; 31(4):406-14. PubMed ID: 10821485
[TBL] [Abstract][Full Text] [Related]
18. Quantitative evaluation of protein expression as a function of tissue microarray core diameter: is a large (1.5 mm) core better than a small (0.6 mm) core?
Anagnostou VK; Lowery FJ; Syrigos KN; Cagle PT; Rimm DL
Arch Pathol Lab Med; 2010 Apr; 134(4):613-9. PubMed ID: 20367312
[TBL] [Abstract][Full Text] [Related]
19. Quality aspects of the tissue microarray technique in a population-based cohort with ductal carcinoma in situ of the breast.
Wärnberg F; Amini RM; Goldman M; Jirström K
Histopathology; 2008 Dec; 53(6):642-9. PubMed ID: 19076680
[TBL] [Abstract][Full Text] [Related]
20. Hashimoto's thyroiditis with papillary thyroid carcinoma (PTC)-like nuclear alterations express molecular markers of PTC.
Prasad ML; Huang Y; Pellegata NS; de la Chapelle A; Kloos RT
Histopathology; 2004 Jul; 45(1):39-46. PubMed ID: 15228442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
